Soluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease

被引：4
|
作者：
Afangbedji, Nowah [1 ,2 ]
Kumari, Namita [1 ]
Diaz, Sharmin [1 ]
Wen, Fayuan [1 ]
Taylor, James G. [1 ,3 ]
Nekhai, Sergei [1 ,3 ,4 ]
Jerebtsova, Marina [4 ,5 ]
机构：
[1] Howard Univ, Ctr Sickle Cell, Washington, DC USA
[2] Howard Univ, Dept Physiol & Biophys, Washington, DC USA
[3] Howard Univ, Dept Med, Washington, DC USA
[4] Howard Univ, Coll Med, Dept Microbiol, Washington, DC USA
[5] Howard Univ, Coll Med, Dept Microbiol, Room 311,520 St NW, Washington, DC 20059 USA
来源：
BLOOD ADVANCES | 2023年 / 7卷 / 09期
基金：
美国国家卫生研究院;
关键词：
UPAR;
D O I：
10.1182/bloodadvances.2022008374
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1854 / 1857
页数：4
相关论文
共 50 条
  • [1] Plasma Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as an Early Indicator of Sickle Cell Disease-Associated Chronic Kidney Disease
    Afangbedji, Nowah
    Taye, Ammanuel
    Smith, Nathan
    Niu, Xiomei
    Taylor, James G.
    Nekhai, Sergei
    Jerebtsova, Marina
    FASEB JOURNAL, 2019, 33
  • [2] Elevated Plasma Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Sickle Cell Disease - a Marker of Chronic Kidney Disease
    Afangbedji, Nowah Kokou Apeadoufia
    Taylor, James G.
    Nekhai, Sergei
    Jerebtsova, Marina
    BLOOD, 2021, 138
  • [3] Soluble urokinase-type plasminogen activator surface receptor is associated with kidney disease in heart failure patients
    Dieden, A.
    Holm, H.
    Korduner, J.
    Nezami, Z.
    Zaghi, A.
    Bachus, E.
    Molvin, J.
    Gudmundsson, P.
    Jujic, A.
    Magnusson, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 114 - 114
  • [4] SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS ASSOCIATED WITH KDIGO CHRONIC KIDNEY DISEASE STAGE IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
    Yussef, Sarah Mohammed
    Ursli, Martin
    Rothschild, Inke
    Faraj-Allah, Ayah
    Koppensteiner, Renate
    Schernthaner, Gerit-Holger
    Hoebaus, Clemens
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 161 - 161
  • [5] SOLUBLE UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR AS A PREDICTOR OF CHRONIC KIDNEY DISEASE
    Ferreira, Ana Carina
    Verdelho, Miguel
    Santos, Maria Ceu
    Nolasco, Fernando
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 165 - 165
  • [6] Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia
    Zahr, Rima S.
    Rashkin, Sara R.
    Ruiz, Maria Armila
    Elsherif, Laila
    Ren, Guohui
    Salas, Guadalupe
    Ataga, Kenneth I.
    Gordeuk, Victor R.
    Lebensburger, Jeffrey
    Zhang, Xu
    Saraf, Santosh L.
    HAEMATOLOGICA, 2024, 109 (10) : 3368 - 3372
  • [7] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Anis Ismail
    Salim S. Hayek
    Current Cardiology Reports, 2023, 25 : 1797 - 1810
  • [8] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Ismail, Anis
    Hayek, Salim S.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (12) : 1797 - 1810
  • [9] A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
    Spinale, Joann M.
    Mariani, Laura H.
    Kapoor, Shiv
    Zhang, Jidong
    Weyant, Robert
    Song, Peter X.
    Wong, Hetty N.
    Troost, Jonathan P.
    Gadegbeku, Crystal A.
    Gipson, Debbie S.
    Kretzler, Matthias
    Nihalani, Deepak
    Holzman, Lawrence B.
    KIDNEY INTERNATIONAL, 2015, 87 (03) : 564 - 574
  • [10] Soluble Urokinase-type Plasminogen Activator Receptor is associated with progression of hypertension-attributed chronic kidney disease in African Americans
    Luo, Shengyuan
    Coresh, Josef
    Tin, Adrienne
    Rebholz, Casey M.
    Chen, Teresa K.
    Hayek, Salim S.
    Tracy, Melissa
    Lipkowitz, Michael S.
    Appel, Lawrence J.
    Levey, Andrew S.
    Inker, Lesley A.
    Reiser, Jochen
    Grams, Morgan E.
    CIRCULATION, 2018, 137
12345